A new report says that as many as one third of the antimalarial drugs sold in south Asian and sub Saharan African countries are counterfeit or of such poor quality as to be ineffective. Experts say this not only jeopardizes the progress made against malaria in the past decade, but also is speeding the emergence of drug resistance in the malaria parasite. Experts have known for years that fake, poor quality, and improperly-packaged drugs pose a serious public health threat in many ...
No comments:
Post a Comment